Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020

High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!

(2021) Susy Fanny Núñez-Zapata et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case−control study

(2020) Alex Carignan et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020

(2020) Neeraj Sood et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG

(2020) Alexander Krüttgen et al.   JOURNAL OF CLINICAL VIROLOGY

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

(2020) Silvia Stringhini et al.   LANCET

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

SARS-CoV-2 seroprevalence in COVID-19 hotspots

(2020) Isabella Eckerle et al.   LANCET

Anosmia as a Prominent Symptom of COVID-19 Infection

(2020) F. Heidari et al.   RHINOLOGY

Reconstructing Mayaro virus circulation in French Guiana shows frequent spillovers

(2020) Nathanaël Hozé et al.   Nature Communications

Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review

(2020) Chih-Cheng Lai et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

(2020) Andrew T. Levin et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY